Inventor
Gideon A. Rodan
Inventor
Bryn Mawr, PA, US
Overview
Patents· 25 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes24%
C07KPeptides22%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations15%
G01NInvestigating or analysing materials by determining their chemical or physical properties11%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms7%
C07DHeterocyclic compounds5%
C12NMicroorganisms or enzymes5%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium4%
C07JSteroids4%
C07CAcyclic or carbocyclic compounds2%
PatentTitleYear
7,306,903'Methods and compositions for identifying morphogen analogs'20076,645,974'Androgen receptor modulators and methods for use thereof'20036,586,457'Methods for inhibiting bone resorption'20036,416,964'Methods of identifying modulators of kinases responsive to stress'20026,414,006'Methods for inhibiting bone resorption'20026,376,477'Combination of an agent that binds to the androgen receptor and a bisphosphonic acid in the prevention and/or treatment of diseases involving calcium or phosphate metabolism'20026,214,564'Method of identifying modulators of protein tyrosine phosphatase activity'20016,093,533'Method of measuring bone resorption activity with a highly enriched population of prefusion osteoclast cells'20006,090,544'Methods and compositions for identifying morphogen analogs'20006,057,113'Mouse integrin subunits'20006,043,026'Combination therapy for the prevention and treatment of osteoporosis'20005,939,322'Human steroid receptor'19995,895,754'Nucleic acids encoding a truncated mouse .beta. integrin subunit'19995,866,397'Human protein tyrosine phosphatase OB protein'19995,856,186'Method for producing a highly enriched population of osteoclast cells'19995,834,188'Methods and compositions for identifying morphogen analogs'19985,780,291'Wnt-x growth factor polypeptide, DNA encoding same, and Wnt-x antibody'19985,719,058'Method for producing a highly enriched population of osteoclast cells'19985,679,518'Method for finding transcription activators of the NER steroid hormone receptor'19975,658,756'CDNA encoding a novel human protein tyrosine phosphatase'19975,607,967'Treatment of alzheimer\'s disease with 5-(tetradecyloxy)-2-furan carboxylic acid'19975,461,034'Osteogenic growth polypeptides identified from regenerating bone marrow'19955,409,911'Prostaglandin analog for treating osteoporosis'19955,270,365'Prevention and treatment of periodontal disease with alendronate'19935,183,815'Bone acting agents'1993Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1993–2003Patents assigned to MERCK & CO INC (21)· patent assignee history
1993–2007Based in Bryn Mawr, PA, US· patent location history
1998Patents assigned to CREATIVE BIOMOLECULE INC (1)· patent assignee history
2000Patents assigned to CREATIVE BIOMOLECULES INC (1)· patent assignee history
2002–2003Patents assigned to MERCK FROSST CANADA INC (2)· patent assignee history
2007Patents assigned to CURIS INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MERCK & CO INC | 21 | 1993–2003 |
| MERCK FROSST CANADA INC | 2 | 2002–2003 |
| CREATIVE BIOMOLECULE INC | 1 | 1998 |
| CREATIVE BIOMOLECULES INC | 1 | 2000 |
| CURIS INC | 1 | 2007 |
Locations
| Location | Patents | Span |
|---|---|---|
| Bryn Mawr, Pennsylvania, US | 25 | 1993–2007 |